The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

In looking across the past four years of regulatory decisions, we noticed that some of the analyses involving the European Medicines Agency (EMA)'s cycle time used an inappropriate endpoint ...

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Indian stock markets remained shut on Monday for Ambedkar Jayanti. Despite a late rebound on Friday following a 90-day U.S.

Ripple’s Garlinghouse says SEC case nearing resolution and touts ETF approval, lifting XRP as bulls eye fresh highs amid ...

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...

Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, has announced an exclusive licensing agreement with pharmaand GmbH (pharma&), a global pharmaceutical company based in Vienna ...

Markets brace for volatility as DAX futures fall 856 points on tariff shock. Trade tensions and Fed signals drive the ...

The EUR/USD pair traded with a slight bearish bias on Tuesday after the European session, slipping mildly toward the 1.0900 ...